SS 25 - Lung 1: Randomized Trials for Lung Cancer

Moderator(s)

• AK

  Aparna Kesarwala, MD, PhD

  Emory University
  Atlanta, GA, United States
• 

  Maria Werner-Wasik, MD, FASTRO

  Thomas Jefferson University
  Philadelphia, PA, United States

Presentations:

• 5:00 PM – 5:10 PM ET

  Long-Term Outcomes of Postoperative Radiotherapy for Patients with pIIIA-N2 Non-Small Cell Lung Cancer after Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial
  

  Presenter: Yu Men, MD – CICAMS and PUMC
• 5:10 PM – 5:20 PM ET

  Long-Term Outcomes of a Prospective Randomized Trial of Passive Scattering Proton Therapy vs. Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
  

  Presenter: Tingshi Su, MD, PhD – MD Anderson Cancer Center
• 5:20 PM – 5:30 PM ET

  The Impact of Prophylactic Bisphosphonates on Radiation-Induced Rib Fractures and Chest Wall Pain in Peripheral Lung Tumor SBRT: A Randomized, Double-Blind, Placebo-Controlled Study
  

  Presenter: Michael Farris, MD – Wake Forest University Medical Center
• 5:30 PM – 5:40 PM ET

  Incidence of Pulmonary Hypertension and Association with Pulmonary Artery Radiation Dose in Lung Cancer Radiotherapy
  

  Presenter: Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center
• 5:40 PM – 5:50 PM ET

  Exploratory Analysis of ctDNA and Imaging Response in the Phase I/II CHORUS Study of Canakinumab with Chemoradiation and Durvalumab Consolidation for Stage III NSCLC
  

  Presenter: Narek Shaverdian, MD – Memorial Sloan Kettering Cancer Center